# A Study of Patients Receiving Adjuvant Nivolumab Therapy for Melanoma That Has Been Removed

> **NCT03771859** · — · UNKNOWN · sponsor: **Bristol-Myers Squibb** · enrollment: 152 (actual)

## Conditions studied

- Melanoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03771859
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-16
- **Primary completion:** 2025-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2021-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03771859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03771859, "A Study of Patients Receiving Adjuvant Nivolumab Therapy for Melanoma That Has Been Removed". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03771859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*